Stay updated on RMC-6236 in RAS Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.

Latest updates to the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedThe page now displays Revision: v3.5.3, replacing the previous Revision: v3.5.2. This reflects a minor version update to the page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedFooter revision label updated to Revision: v3.5.2. The previous Revision: v3.5.0 entry was removed.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated to v3.4.3. Previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check60 days agoChange DetectedAdded a publication entry for the 2024 article Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers and removed the Erratum entry for that article.SummaryDifference0.0%

- Check81 days agoChange DetectedAdded Revision: v3.4.2 and removed the notices for v3.4.1 and the government funding lapse message. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to RMC-6236 in RAS Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RMC-6236 in RAS Mutant Solid Tumors Clinical Trial page.